Funded startups/BridgeHealth Pharmaceuticals, Inc.
BP

BridgeHealth Pharmaceuticals, Inc.

SEC filing
Pharmaceuticals · Woburn, MA
Form D on EDGAR
Amount raised$3.5Msold at filing
Total offering$3.5M
Investors in the raise5count reported to the SEC
FiledNov 5, 2026first sale Oct 22, 2026

Form D does not name the investors. If a news report names them, they appear here.

Named in the filing

Neal MuniExecutive Officer, Director
Indu MuniExecutive Officer, Director
Howard AckermanDirector

Executive officers, directors and promoters as listed on the Form D.